• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病中的路易小体:与α-突触核蛋白聚集体形成和降解相关的分子。

The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.

作者信息

Wakabayashi Koichi, Tanji Kunikazu, Mori Fumiaki, Takahashi Hitoshi

机构信息

Department of Neuropathology, Institute of Brain Science, Hirosaki University School of Medicine, Hirosaki, Japan.

出版信息

Neuropathology. 2007 Oct;27(5):494-506. doi: 10.1111/j.1440-1789.2007.00803.x.

DOI:10.1111/j.1440-1789.2007.00803.x
PMID:18018486
Abstract

The histological hallmark of Parkinson's disease (PD) is the presence of fibrillar aggregates called Lewy bodies (LBs). LB formation has been considered to be a marker for neuronal degeneration, because neuronal loss is found in the predilection sites for LBs. To date, more than 70 molecules have been identified in LBs, in which alpha-synuclein is a major constituent of LB fibrils. Alpha-synuclein immunohistochemistry reveals that diffuse cytoplasmic staining develops into pale bodies via compaction, and that LBs arise from the peripheral portion of pale bodies. This alpha-synuclein abnormality is found in 10% of pigmented neurons in the substantia nigra and more than 50% of those in the locus ceruleus in PD. Recent studies have suggested that oligomers and protofibrils of alpha-synuclein are cytotoxic, and that LBs may represent a cytoprotective mechanism in PD.

摘要

帕金森病(PD)的组织学特征是存在称为路易小体(LBs)的纤维状聚集体。路易小体的形成一直被认为是神经元变性的标志,因为在路易小体的好发部位发现了神经元丢失。迄今为止,已在路易小体中鉴定出70多种分子,其中α-突触核蛋白是路易小体纤维的主要成分。α-突触核蛋白免疫组织化学显示,弥漫性细胞质染色通过压实发展为浅色小体,并且路易小体起源于浅色小体的周边部分。在帕金森病中,这种α-突触核蛋白异常在黑质中10%的色素神经元以及蓝斑中超过50%的色素神经元中被发现。最近的研究表明,α-突触核蛋白的寡聚体和原纤维具有细胞毒性,并且路易小体可能代表帕金森病中的一种细胞保护机制。

相似文献

1
The Lewy body in Parkinson's disease: molecules implicated in the formation and degradation of alpha-synuclein aggregates.帕金森病中的路易小体:与α-突触核蛋白聚集体形成和降解相关的分子。
Neuropathology. 2007 Oct;27(5):494-506. doi: 10.1111/j.1440-1789.2007.00803.x.
2
[Lewy body formation in Parkinson's disease: neurodegeneration or neuroprotection?].[帕金森病中的路易小体形成:神经退行性变还是神经保护?]
Rinsho Shinkeigaku. 2008 Nov;48(11):981-3. doi: 10.5692/clinicalneurol.48.981.
3
The Lewy body in Parkinson's disease and related neurodegenerative disorders.路易体在帕金森病及相关神经退行性疾病中的作用。
Mol Neurobiol. 2013 Apr;47(2):495-508. doi: 10.1007/s12035-012-8280-y. Epub 2012 May 24.
4
[The mechanism of Lewy body formation in Parkinson's disease].[帕金森病中路易小体形成的机制]
Nihon Rinsho. 2000 Oct;58(10):2022-7.
5
Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.散发性帕金森病和路易体痴呆患者路易小体中α-突触核蛋白的聚集。
Am J Pathol. 1998 Apr;152(4):879-84.
6
Colocalization of tau and alpha-synuclein epitopes in Lewy bodies.路易小体中tau蛋白和α-突触核蛋白表位的共定位。
J Neuropathol Exp Neurol. 2003 Apr;62(4):389-97. doi: 10.1093/jnen/62.4.389.
7
Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.α-突触核蛋白免疫反应性皮质路易小体与帕金森病的认知障碍有关。
Acta Neuropathol. 2000 Sep;100(3):285-90. doi: 10.1007/s004019900168.
8
Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.在帕金森病早期,α-突触核蛋白重新分布至黑质中的神经黑素脂质。
Brain. 2005 Nov;128(Pt 11):2654-64. doi: 10.1093/brain/awh584. Epub 2005 Jul 6.
9
Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.散发性帕金森病和路易体痴呆患者路易小体中磷酸化tau蛋白和NACP/α-突触核蛋白表位的细胞共定位。
Brain Res. 1999 Oct 2;843(1-2):53-61. doi: 10.1016/s0006-8993(99)01848-x.
10
Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.帕金森病和皮质路易体病中的黑质和皮质路易小体以及营养不良性黑质神经突含有α-突触核蛋白免疫反应性。
J Neuropathol Exp Neurol. 1998 Apr;57(4):334-7. doi: 10.1097/00005072-199804000-00005.

引用本文的文献

1
N-Homocysteinylation of lysine residues in α-Synuclein enhances aggregation propensity and cytotoxicity in SH-SY5Y cells.α-突触核蛋白中赖氨酸残基的N-同型半胱氨酸化增强了SH-SY5Y细胞中的聚集倾向和细胞毒性。
Sci Rep. 2025 Jul 2;15(1):23028. doi: 10.1038/s41598-025-08186-w.
2
α-Synuclein Pathology in Synucleinopathies: Mechanisms, Biomarkers, and Therapeutic Challenges.突触核蛋白病中的α-突触核蛋白病理学:机制、生物标志物及治疗挑战
Int J Mol Sci. 2025 Jun 4;26(11):5405. doi: 10.3390/ijms26115405.
3
Regulatory mechanism of circular RNAs in brain and neurodegenerative diseases.
环状RNA在脑和神经退行性疾病中的调控机制。
Front Mol Neurosci. 2025 May 16;18:1507575. doi: 10.3389/fnmol.2025.1507575. eCollection 2025.
4
Neuron-Derived Extracellular Vesicles: Emerging Regulators in Central Nervous System Disease Progression.神经元衍生的细胞外囊泡:中枢神经系统疾病进展中的新兴调节因子
Mol Neurobiol. 2025 May 6. doi: 10.1007/s12035-025-05010-4.
5
Abundant non-inclusion α-synuclein pathology in Lewy body-negative LRRK2-mutant cases.路易体阴性的LRRK2突变病例中存在大量非包涵体型α-突触核蛋白病理改变。
Acta Neuropathol. 2025 May 2;149(1):41. doi: 10.1007/s00401-025-02871-w.
6
α-synuclein and tau: interactions, cross-seeding, and the redefinition of synucleinopathies as complex proteinopathies.α-突触核蛋白与tau蛋白:相互作用、交叉播种以及将突触核蛋白病重新定义为复杂蛋白质病
Front Neurosci. 2025 Mar 27;19:1570553. doi: 10.3389/fnins.2025.1570553. eCollection 2025.
7
Inspecting the Triazole Scaffold as Powerful Antifibril Agents against 2N4R Tau and α-Synuclein Aggregates.将三唑支架作为针对2N4R Tau和α-突触核蛋白聚集体的强效抗纤维化剂进行研究。
ACS Omega. 2025 Feb 12;10(7):6721-6734. doi: 10.1021/acsomega.4c08385. eCollection 2025 Feb 25.
8
Aberrant accumulation of phosphorylated BRCA1 in brainstem-type and cortical-type Lewy bodies in Lewy body disease.在路易体病的脑干型和皮质型路易小体中,磷酸化BRCA1异常积聚。
J Neuropathol Exp Neurol. 2025 Apr 1;84(4):276-285. doi: 10.1093/jnen/nlaf004.
9
Evolving Landscape of Parkinson's Disease Research: Challenges and Perspectives.帕金森病研究的发展态势:挑战与展望
ACS Omega. 2025 Jan 8;10(2):1864-1892. doi: 10.1021/acsomega.4c09114. eCollection 2025 Jan 21.
10
Associations Between Diabetes Mellitus and Neurodegenerative Diseases.糖尿病与神经退行性疾病之间的关联。
Int J Mol Sci. 2025 Jan 10;26(2):542. doi: 10.3390/ijms26020542.